Fri, February 14, 2020

Robyn Karnauskas Maintained (BTAI) at Strong Buy with Increased Target to $150 on, Feb 14th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-150-on-feb-14th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Robyn Karnauskas of SunTrust Robinson Humphrey, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $24 to $150 on, Feb 14th, 2020.

Robyn has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Robyn's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robyn


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $30 on, Wednesday, January 8th, 2020


Similar Stocks and Investing Publications